TrialSignal transduction and targeted therapy2023

Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial.

Shun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.